looks like they have enough cash until end of FY at this rate. not sure what happens after.
though $0.4m was a one off bonus expense for the IPO and the company is due to receive $3m back in tax concessions for R&D in 6 months.
also sales improved around 30% Q2 on Q1 but I have to be honest I have no idea of when the CryoShot is going to be in production and sale - anyone?